reseligo
zentiva k.s. - goserelinas - implantas užpildytame švirkšte - 3,6 mg - goserelin
algonad
zentiva k.s. - goserelinas - implantas užpildytame švirkšte - 10,8 mg - goserelin
zoladex la
astrazeneca ab - goserelinas - implantas - 3,6 mg; 10,8 mg - goserelin
xanderla
teva b.v. - goserelinas - implantas užpildytame švirkšte - 3,6 mg - goserelin
goserelin teva
teva b.v. - goserelinas - implantas užpildytame švirkšte - 10,8 mg - goserelin
firmagon
ferring pharmaceuticals a/s - degareliksas - prostatos navikai - endokrininė terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
anastrozole accord
accord healthcare b.v. - anastrozolas - plėvele dengtos tabletės - 1 mg - anastrozole
axastrol
as grindeks - anastrozolas - plėvele dengtos tabletės - 1 mg - anastrozole
bicalutamide grindeks
as grindeks - bikalutamidas - plėvele dengtos tabletės - 50 mg - bicalutamide
bicalutamide kabi
fresenius kabi polska sp.z.o.o. - bikalutamidas - plėvele dengtos tabletės - 50 mg - bicalutamide